Milan, 24 April 2020 - The IFCC, the international leading organization in the field of Clinical Chemistry and Laboratory Medicine, is pleased to announce that Dr Jean Baptiste WOILLARD (TDM and Pharmacokinetics Unit, University Hospital of Limoges, Limoges, France), has been selected to receive the 2020 IFCC-Gérard Siest Young Scientist Award for Distinguished Contributions in Pharmacogenetics, sponsored by Biologie Prospective. This award recognizes an outstanding young investigator or young leader (under 40 years of age) for his/her contribution to advancing the scientific discipline of pharmacogenomics and Personalized/Precision Medicine and/or its impact on research, development, standardization, quality management, regulatory evaluation or utilization in therapy. The IFCC is very pleased to acknowledge the support by Biologie Prospective in the recognition of scientists and educators with a distinguished career in this area.
Dr Woillard is a young Assistant Professor of Pharmacology in Limoges medical school. He heads the TDM and Pharmacokinetics Unit, Department of Pharmacology, Toxicology, and Pharmacovigilance, and he is a researcher in the INSERM UMR-S1248 research team entitled “Pharmacology of immunosuppressants and transplantation ».Member of the “International Association of Therapeutic Drug Monitoring and Clinical Toxicology" (IATDMCT) and vice-chair of the Pharmacometrics committee he is also member of the ISOP-ACCP Clinical Pharmacometrics Special Interest Group Steering Committee (Chair M Neely). He was awarded by the French Society of Pharmacology and Therapeutics in 2015 and 2017. He has recognized expertise in translation from basic research to clinical biology laboratories in the field of pharmacogenomic and pharmacology. He has coauthored 56 national and international publications
Prof. Maurizio FERRARI, IFCC President and Chair IFCC Awards Committee, said: "We are delighted in selecting Dr Jean Baptiste WOILLARD for the 2020 IFCC-Gérard Siest Young Scientist Award for Distinguished Contributions in Pharmacogenetics. He has a remarkable career in the field of clinical chemistry and laboratory medicine and, despite his young age, he is an already experienced and committed scientist. I believe that he well deserves the 2020 IFCC-Gérard Siest Young Scientist Award for Distinguished Contributions in Pharmacogenetics.
The 2020 IFCC Awardees are a witness of the contribution that IFCC gives to advancement of excellence in laboratory medicine for better healthcare worldwide. Dr Woillard, along with nine other IFCC Distinguished Award winners, will be formally announced on Wednesday 6th January 2021 at the Opening Ceremony of the 24th WorldLab - IFCC International Congress in Clinical Chemistry and Laboratory Medicine to be held in Seoul (South Korea) from 6th to 10th January 2021.
- end -
click here to read the press release
IFCC is the leading organization in the field of Clinical Chemistry and Laboratory Medicine worldwide. Through leadership and innovation in science and education, IFCC strives to enhance the scientific level and the quality of diagnosis and therapy for patients throughout the world. IFCC builds on the professionalism of its members to provide quality services to patients. IFCC is a Federation of 93 Full Member and 17 Affiliate member Societies of Clinical Chemistry and Laboratory Medicine representing more than 45.000 individual clinical chemists, laboratory scientists, and laboratory physicians and 48 Corporate Members covering the major areas of clinical laboratory developments. For further details please contact: email@example.com.
ABOUT Biologie Prospective
Biologie Prospective is an association law 1901 founded in 1969. Its mission is the promotion of research and development in the biological, pharmaceutical, clinical, pharmacological and toxicological sciences and the organization of quality controls and professional training sessions for private and public medical biology laboratories. Visit: http://www.biologie-prospective.org/index.aspx